GLP-1 receptor agonist (RA) medications are highly effective for managing weight and blood sugar, but they can also disrupt digestive healthleading to discomfort, irregularity, and microbial imbalance
Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine beta-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer
Multiple dose levels (1, 4, 8, 12 mg) were tested in Phase 2, with the Phase 3 dose selection to be refined based on efficacy-tolerability balance
Amazon One Medical (cash pay): Oral GLP-1 (Foundayo, oral Wegovy): $149/month Injectable GLP-1 (Wegovy, Zepbound): $299/month New patient consultation: billed separately per visit On-demand renewal (message): $29 per request On-demand renewal (video): $49 per request One Medical membership (optional): $199/year Direct Meds (cash pay): Compounded semaglutide: below Amazon's injectable floor Consultation included within program structure No membership fees No per-renewal charges during active treatment The bottom line for cash-pay patients: Direct Meds delivers a lower total monthly cost for patients seeking injectable compounded semaglutide - with consultation costs built into the program rather than stacked on top of medication costs